Patent 7625923 was granted and assigned to Bristol-Myers Squibb on December, 2009 by the United States Patent and Trademark Office.
The present invention relates to bicyclic compounds according to formula I, pharmaceutical compositions containing such compounds and methods of using such compounds in the treatment of androgen receptor-associated conditions, such as age-related diseases, for example sarcopenia,